Joanna C Neill
Overview
Explore the profile of Joanna C Neill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Woods R, Lorusso J, Potter H, Neill J, Glazier J, Hager R
Neurosci Biobehav Rev
. 2021 Jul;
129:389-421.
PMID: 34280428
Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring neurodevelopment and predispose offspring to neurodevelopmental disorders such as schizophrenia. Rodent models of mIA have explored possible mechanisms underlying...
12.
Hojlund M, Kemp A, Haddad P, Neill J, Correll C
Lancet Psychiatry
. 2021 May;
8(6):471-486.
PMID: 34023019
Background: Dose reduction of antipsychotic maintenance treatment in individuals with schizophrenia could be desirable to minimise adverse effects, but evidence for this strategy is unclear. We aimed to compare risks...
13.
Begni V, Sanson A, Luoni A, Sensini F, Grayson B, Munni S, et al.
Int J Mol Sci
. 2021 Apr;
22(8).
PMID: 33923479
Schizophrenia is a complex psychopathology whose treatment is still challenging. Given the limitations of existing antipsychotics, there is urgent need for novel drugs with fewer side effects. SEP-363856 (SEP-856) is...
14.
Wood T, Edye M, Harte M, Neill J, Prinssen E, Vernon A
Brain Neurosci Adv
. 2019 Nov;
3:2398212819883086.
PMID: 31742236
Maternal immune activation is consistently associated with elevated risk for multiple psychiatric disorders in the affected offspring. Related to this, an important goal of our work is to explore the...
15.
Kassab S, Begley P, Church S, Rotariu S, Chevalier-Riffard C, Dowsey A, et al.
Mol Metab
. 2019 Aug;
28:107-119.
PMID: 31451429
Objective: The impact of diabetes mellitus on the central nervous system is less widely studied than in the peripheral nervous system, but there is increasing evidence that it elevates the...
16.
Atique-Ur-Rehman H, Neill J
Pharmacol Ther
. 2019 Jun;
202:53-71.
PMID: 31173838
Major depressive disorder (MDD) is a disabling disease associated with profound functional impairment. Cognitive deficits, increasingly recognised as a core feature of MDD, reduce educational, occupational and social outcomes, and...
17.
Doostdar N, Kim E, Grayson B, Harte M, Neill J, Vernon A
J Psychopharmacol
. 2019 May;
33(10):1274-1287.
PMID: 31060435
Background: Cognitive deficits and structural brain changes co-occur in patients with schizophrenia. Improving our understanding of the relationship between these is important to develop improved therapeutic strategies. Back-translation of these...
18.
Freeman T, Mehta M, Neill J, Nutt D, Tunbridge E, Young A
J Psychopharmacol
. 2018 Oct;
32(10):1053-1055.
PMID: 30278146
No abstract available.
19.
Murray K, Edye M, Manca M, Vernon A, Oladipo J, Fasolino V, et al.
Brain Behav Immun
. 2018 Sep;
75:48-59.
PMID: 30218784
Maternal immune activation (mIA) in rodents is rapidly emerging as a key model for neurodevelopmental disorders such as autism spectrum disorder (ASD) and schizophrenia. Here, we optimise a mIA model...
20.
Watremez W, Jackson J, Almari B, McLean S, Grayson B, Neill J, et al.
J Alzheimers Dis
. 2018 Feb;
62(1):213-226.
PMID: 29439327
Background: With current treatments for Alzheimer's disease (AD) only providing temporary symptomatic benefits, disease modifying drugs are urgently required. This approach relies on improved understanding of the early pathophysiology of...